Normal view MARC view ISBD view

Aspirin therapy in type 2 diabetes in a general practice in Italy. [electronic resource]

By:

Passamonti, Marco

Contributor(s):

Producer: 20040325Description: 99-100 p. digitalISSN:

1381-4788

Subject(s):

Online resources:

Available from publisher's website

In: The European journal of general practice vol. 9

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Letter

There are no comments on this title.

to post a comment.

Back to results

101 Etoposide (E) + epirubicin (E) + cisplatin (P) combination chemotherapy (EEP) in advanced gastric cancer: negative impact on clinical outcome. Spanish Cooperative Group for GI Tumor Therapy (T.T.D.).
by Díaz-Rubio, E
102 Therapeutic equivalence of single oral doses of dolasetron mesilate and multiple doses of ondansetron for the prevention of emesis after moderately emetogenic chemotherapy. European Dolasetron Comparative Study Group.
by Fauser, A A
103 Oxaliplatin as single agent in previously untreated colorectal carcinoma patients: a phase II multicentric study.
by Díaz-Rubio, E
104 Phase II trial of UFT activity in pretreated breast cancer patients.
by Daniels, M
105 Paclitaxel plus vinorelbine: an active regimen in metastatic breast cancer patients with prior anthracycline exposure.
by Martín, M
106 APC Yin-Yang haplotype associated with colorectal cancer risk.
by Garre, P
107 Treatment of advanced ovarian cancer with cisplatin, adriamycin and cyclophosphamide (PAC).
by Diaz-Rubio, E
108 Combination of oral idarubicin and prednimustine in advanced breast cancer: a phase II study.
by Barnadas, A
109 Tegafur and uracil plus leucovorin in advanced colorectal cancer: a phase II trial.
by Aranda, E
110 Irinotecan-cetuximab-bevacizumab as a salvage treatment in heavily pretreated metastatic colorectal cancer patients: a retrospective observational study.
by Feliu Batlle, J
111 Gastrointestinal Tract Cancer Liaison Office: an attempt to organise clinical research in Europe.
by Bleiberg, H
112 Pathological complete response following docetaxel-based neoadjuvant chemotherapy for locally advanced gastric adenocarcinoma.
by Bueno Muiño, C
113 [A randomized study of navelbine compared to navelbine and cisplatin compared to vindesine and cisplatin in the treatment of inoperable non-small-cell lung carcinoma. The results of a European multicenter study including 612 patients].
by González Larriba, J L
114 First-line single-agent cetuximab in elderly patients with metastatic colorectal cancer. A phase II clinical and molecular study of the Spanish group for digestive tumor therapy (TTD).
by Sastre, J
115 Outpatient weekly high-dose continuous-infusion 5-fluorouracil plus oral leucovorin in advanced colorectal cancer. A phase II trial. Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD).
by Aranda, E
116 Comparative survival analysis of p53 gene mutations and protein accumulation in colorectal cancer.
by Caldes, T
117 Pre-test prediction models of BRCA1 or BRCA2 mutation in breast/ovarian families attending familial cancer clinics.
by de la Hoya, M
118 Cooperative role of telomerase activity and p16 expression in the prognosis of non-small-cell lung cancer.
by González-Quevedo, Rosa
119 p53 exon 5 mutations as a prognostic indicator of shortened survival in non-small-cell lung cancer.
by Vega, F J
120 Celecoxib in a 12-year-old boy with familial adenomatous polyposis.
by Pérez-Segura, P